Laurus Labs Limited (LAURUSLABS.BO)
INR 571.2
(0.69%)
INR 571.2
(0.69%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 18.45 Billion INR | 9.53% |
| 2022 | 16.84 Billion INR | -4.29% |
| 2021 | 17.6 Billion INR | 11.73% |
| 2020 | 15.75 Billion INR | 74.04% |
| 2019 | 9.05 Billion INR | 32.74% |
| 2018 | 6.81 Billion INR | 16.61% |
| 2017 | 5.84 Billion INR | 14.88% |
| 2016 | 5.09 Billion INR | 4.51% |
| 2015 | 4.87 Billion INR | 2.44% |
| 2014 | 4.75 Billion INR | 44.93% |
| 2013 | 3.28 Billion INR | 110.06% |
| 2012 | 1.56 Billion INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 21.07 Billion INR | 0.0% |
| 2023 Q4 | 18.45 Billion INR | 0.0% |
| 2023 Q2 | 18.65 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 18.45 Billion INR | 9.53% |
| 2022 Q2 | 22.61 Billion INR | 0.0% |
| 2022 Q4 | 16.84 Billion INR | 0.0% |
| 2022 FY | 16.84 Billion INR | -4.29% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q2 | 18.95 Billion INR | 0.0% |
| 2021 FY | 17.6 Billion INR | 11.73% |
| 2021 Q4 | 17.6 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q4 | 15.75 Billion INR | 0.0% |
| 2020 FY | 15.75 Billion INR | 74.04% |
| 2020 Q2 | 11.48 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q4 | 9.05 Billion INR | 0.0% |
| 2019 FY | 9.05 Billion INR | 32.74% |
| 2019 Q2 | 8.97 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 6.81 Billion INR | 0.0% |
| 2018 FY | 6.81 Billion INR | 16.61% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 6.48 Billion INR | 0.0% |
| 2017 Q2 | 5.7 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 5.84 Billion INR | 0.0% |
| 2017 FY | 5.84 Billion INR | 14.88% |
| 2016 Q2 | 5.21 Billion INR | 0.0% |
| 2016 FY | 5.09 Billion INR | 4.51% |
| 2016 Q4 | 5.09 Billion INR | 0.0% |
| 2016 Q1 | - INR | 0.0% |
| 2015 FY | 4.87 Billion INR | 2.44% |
| 2014 FY | 4.75 Billion INR | 44.93% |
| 2013 FY | 3.28 Billion INR | 110.06% |
| 2012 FY | 1.56 Billion INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Ajanta Pharma Limited | 8.28 Billion INR | -122.779% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -6284.463% |
| Sigachi Industries Limited | 707.2 Million INR | -2509.434% |
| Bal Pharma Limited | 878.11 Million INR | -2001.561% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -17546.423% |
| Medico Remedies Limited | 163.37 Million INR | -11195.754% |
| Lasa Supergenerics Limited | 190.43 Million INR | -9590.549% |
| Venus Remedies Limited | 1.21 Billion INR | -1416.485% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Alpa Laboratories Limited | 136.65 Million INR | -13404.35% |
| Nectar Lifesciences Limited | 7.09 Billion INR | -160.228% |
| Shilpa Medicare Limited | 3.44 Billion INR | -435.013% |
| Aarti Drugs Limited | 4.85 Billion INR | -279.8% |
| Lupin Limited | 49.53 Billion INR | 62.748% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 81.185% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 46.384% |
| Windlas Biotech Limited | 621.89 Million INR | -2867.422% |
| Suven Life Sciences Limited | 7.08 Million INR | -260367.184% |
| Eris Lifesciences Limited | 1.89 Billion INR | -876.242% |
| Valiant Laboratories Limited | 100.15 Million INR | -18325.724% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -267.238% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -413.041% |
| Ipca Laboratories Limited | 24.71 Billion INR | 25.327% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -1458.001% |
| Achyut Healthcare Limited | 568 Thousand INR | -3248861.268% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 81.3% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -1181.195% |
| RPG Life Sciences Limited | 1.01 Billion INR | -1727.139% |
| Mankind Pharma Limited | 15.53 Billion INR | -18.793% |
| Piramal Pharma Limited | 21.75 Billion INR | 15.188% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -8653.694% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 19.025% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | -12.283% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 26.567% |
| Unichem Laboratories Limited | 7.04 Billion INR | -161.881% |
| Sequent Scientific Limited | 3.46 Billion INR | -432.998% |
| Novartis India Limited | 448.6 Million INR | -4013.709% |
| Wanbury Limited | 360.23 Million INR | -5022.838% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -698.203% |
| Wockhardt Limited | 6.4 Billion INR | -188.345% |
| Themis Medicare Limited | 705.74 Million INR | -2514.847% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -12205.194% |
| Jubilant Pharmova Limited | 12.89 Billion INR | -43.099% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | -176.843% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 70.962% |
| Divi's Laboratories Limited | 31.84 Billion INR | 42.041% |
| NATCO Pharma Limited | 7 Billion INR | -163.442% |
| Gufic Biosciences Limited | 2 Billion INR | -820.486% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -334.378% |
| Ind-Swift Limited | 640.91 Million INR | -2779.337% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -1591.33% |
| FDC Limited | 3.88 Billion INR | -374.534% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -18737.634% |
| Granules India Limited | 13 Billion INR | -41.895% |
| Medicamen Biotech Limited | 593.75 Million INR | -3008.048% |
| Alkem Laboratories Limited | 26.61 Billion INR | 30.654% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -709.809% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -72277.535% |
| Brooks Laboratories Limited | 96.1 Million INR | -19101.419% |
| Megasoft Limited | - INR | -Infinity% |
| ZIM Laboratories Limited | 812.62 Million INR | -2170.913% |
| Strides Pharma Science Limited | 11.26 Billion INR | -63.856% |
| Neuland Laboratories Limited | 3.5 Billion INR | -426.625% |
| Morepen Laboratories Limited | 2.48 Billion INR | -642.338% |
| Hikal Limited | 3.03 Billion INR | -507.602% |
| Indoco Remedies Limited | 3.53 Billion INR | -422.69% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | -187.063% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -46174.072% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -1392.57% |
| Hester Biosciences Limited | 755.81 Million INR | -2341.632% |